GlassScriptPhysician profile
Jaslynn Kaur Kalsi
NPI 1407377518
$554.46
in general payments reported to CMS, 2019-2025
9 companies · $74.65 in 2025
The $74.65 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.44 · 2021: $206 · 2022: $262 · 2025: $74.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $45.89 · Food and Beverage: $28.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $45.89 |
| Food and Beverage | $28.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $402.42 | 2021-2022 | |
| Colgate Oral Pharmaceuticals, INC. | $45.89 | 2025 | |
| 3m Company | $19.81 | 2022 | |
| Kerr Corporation | $16.82 | 2022 | |
| Philips North America LLC | $14.71 | 2025 | Pic Ix Mobility |
| Align Technology, INC. | $14.58 | 2021 | |
| Solventum Corporation | $14.05 | 2025 | Clarity Aligners, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Dentsply Sirona INC | $13.74 | 2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaslynn Kalsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.